DeutschNewstral
Moderna Contacts
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccinekansascity.com
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19sacbee.com- CModerna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congresscharlotteobserver.com
- CModerna and OpenAI Collaborate To Advance mRNA Medicinecharlotteobserver.com
- Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccinesacbee.com
- CPhase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meetingcharlotteobserver.com
Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Sciencethenewstribune.com- PModerna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapiesproduction.kansascity.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.